(Q38010795)

26 August 2017

title

Untangling asthma phenotypes and endotypes (English)

1 reference

26 August 2017

1 reference

1 reference

3

M Jutel

1 reference

26 August 2017

I Agache

1

1 reference

26 August 2017

C Akdis

series ordinal

2

1 reference

26 August 2017

J C Virchow

series ordinal

4

1 reference

26 August 2017

publication date

17 May 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

67

1 reference

26 August 2017

issue

7

1 reference

26 August 2017

page(s)

835-846

1 reference

Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Innate immune activation in neutrophilic asthma and bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Different inflammatory phenotypes in adults and children with acute asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Increases in airway eosinophilia and a th1 cytokine during the chronic asymptomatic phase of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Identifying adult asthma phenotypes using a clustering approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor beta in steroid-resistant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Regulatory haplotypes in ARG1 are associated with altered bronchodilator response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Phenotypes of childhood asthma: are they real?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Lebrikizumab treatment in adults with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Exhaled nitric oxide thresholds associated with a sputum eosinophil count >=3% in a cohort of unselected patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

How much asthma is really attributable to atopy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Increased IgG antibody-induced cytotoxicity against airway epithelial cells in patients with nonallergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Neutrophilic airway inflammation is a main feature of induced sputum in nonatopic asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Non-eosinophilic asthma: importance and possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Prosurvival activity for airway neutrophils in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Th17 cells: new players in asthma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Aspirin-induced rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

The broken balance in aspirin hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Involvement of 15-lipoxygenase and prostaglandin EP receptors in aspirin-triggered 15-hydroxyeicosatetraenoic acid generation in aspirin-sensitive asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Systemic responses after bronchial aspirin challenge in sensitive patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Role of staphylococcal superantigen-specific IgE antibodies in aspirin-intolerant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

New insights into the pathophysiology of the small airways in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Pro-angiogenic hematopoietic progenitor cells and endothelial colony-forming cells in pathological angiogenesis of bronchial and pulmonary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Angiogenesis and lymphangiogenesis in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Remodeling of airway walls in fatal asthmatics decreases lymphatic distribution; beyond thickening of airway smooth muscle layers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

The airway epithelium is central to the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Irreversiblity of remodeled features on high-resolution computerized tomography scans of asthmatic patients on conventional therapy: a 6-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Epigenetics and prenatal influences on asthma and allergic airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Common ADRB2 haplotypes derived from 26 polymorphic sites direct beta2-adrenergic receptor expression and regulation phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Slow-responders to IV beta2-adrenergic agonist therapy: defining a novel phenotype in pediatric asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

β2-Agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

The molecular mechanisms of glucocorticoids-mediated neutrophil survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Can inhaled corticosteroids influence the natural history of asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Clarithromycin targets neutrophilic airway inflammation in refractory asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Macrolides as immunomodulatory medications for the therapy of chronic lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

The effect of telithromycin in acute exacerbations of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Mepolizumab and exacerbations of refractory eosinophilic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

SERPINE1 -675 4G/5G polymorphism is associated with asthma severity and inhaled corticosteroid response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

Nonatopic Children with Multitrigger Wheezing Have Airway Pathology Comparable to Atopic Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02832.X

10.1111/J.1398-9995.2012.02832.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference